Good Morning,
Today we are considering an emerging micro cap called RXi Pharmaceuticals (RXII). This company operates within the biopharmaceutical industry, has roughly a $39 million market cap and is listed on the Nasdaq CM. In order to gain more insight on this opportunity, we reached out to Dr. Geert Cauwenbergh, President and Chief Executive Officer of RXi.
Access my article here: http://www.talkmarkets.com/content/us-markets/interview-with-rxi-pharmaceuticals-management?post=44049
No comments:
Post a Comment